FDA Panel Recommends Approval of New Oxycodone Formulation

GAITHERSBURG, Md. (MedPage Today) — An FDA advisory panel voted to recommend approval of a new formulation of oxycodone hydrochloride (OxyContin) that is more difficult to crush or dissolve, and which may deter drug abuse.

Related posts:

1. FDA’s Advisory Committee votes 9-3 to recommend approval of Esbriet for treatment of patients with IPF
2. FDA Panel OKs HPV Vaccine Gardasil for Boys
3. FDA Panels to Review ‘Tamper-Resistant’ Oxycodone